Boston Common Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $549K | Buy |
|
|||||
|
2022
Q3 | $531K | Buy |
|
|||||
|
2022
Q2 | $572K | Buy |
|
|||||
|
2022
Q1 | $499K | Sell |
|
|||||
|
2021
Q4 | $486K | Buy |
|
|||||
|
2021
Q3 | $437K | Buy |
|
|||||
|
2021
Q2 | $493K | Buy |
|
|||||
|
2021
Q1 | $435K | Buy |
|
|||||
|
2020
Q4 | $427K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $3.56M | Sell |
|
|||||
|
2018
Q3 | $5.6M | Sell |
|
|||||
|
2018
Q2 | $5.44M | Sell |
|
|||||
|
2018
Q1 | $6.5M | Buy |
|
|||||
|
2017
Q4 | $6.23M | Buy |
|
|||||
|
2017
Q3 | $6.16M | Sell |
|
|||||
|
2017
Q2 | $5.4M | Sell |
|
|||||
|
2017
Q1 | $5.34M | Buy |
|
|||||
|
2016
Q4 | $4M | Buy |
|
|||||
|
2016
Q3 | $3.64M | Buy |
|
|||||
|
2016
Q2 | $3.83M | Sell |
|
|||||
|
2016
Q1 | $3.42M | Sell |
|
|||||
|
2015
Q4 | $3.72M | Sell |
|
|||||
|
2015
Q3 | $3.4M | Sell |
|
|||||
|
2015
Q2 | $4M | Sell |
|
|||||
|
2015
Q1 | $4.11M | Buy |
|
|||||
|
2014
Q4 | $3.74M | Buy |
|
|||||
|
2014
Q3 | $3.23M | Buy |
|
|||||
|
2014
Q2 | $3.05M | Buy |
|
|||||
|
2014
Q1 | $3.22M | Sell |
|
|||||
|
2013
Q4 | $3.37M | Sell |
|
|||||
|
2013
Q3 | $3.98M | Sell |
|
|||||
|
2013
Q2 | $4.04M | Buy |
|